Stay Connected

Enter your email address to receive science updates from Juul Labs.

Exploring the Real-World Impact of ENDS Products

Smoking-related disease causes nearly one in five premature deaths in the United States (CDC). Half of those who continue to smoke will die from a smoking-related illness — about 480,000 Americans each year, and more than 1,300 every day (CDC).

It is widely understood that the best option for adult smokers to reduce the risks to their health from combustible cigarettes is to quit tobacco and nicotine products altogether. However, for adult smokers who have not successfully quit, noncombustible products, such as electronic nicotine delivery systems (ENDS), or vapor products, can provide adult smokers a potentially less harmful alternative and off-ramp from combustible use.

A growing body of scientific evidence has shown just that. Real-world data and evidence demonstrate that ENDS are viable alternatives to combustible cigarettes for adult smokers, displace cigarette sales and use, and could have a significant public-health benefit by reducing tobacco-related death and disease. 

In the following white paper, Juul Labs has reviewed and compiled the latest science and evidence reinforcing the real-world impact of ENDS products for adult smokers based on four key lines of evidence:

  • Market data demonstrating faster-than-anticipated declines in cigarette sales as a result of ENDS availability;
  • Population surveys demonstrating adult smokers transitioning and completely switching to ENDS products;
  • Economic data demonstrating ENDS products as substitutes to combustible cigarettes; and
  • Population models indicating reductions in tobacco-related death and disease as ENDS use increases.

White Paper: The Real-World Impact of ENDS for Adult Smokers Download PDF

Key Studies on the Real-World Impact of ENDS Products

ENDS Health Effects

Perceptions on Nicotine and Relative Risk